剖宫产瘢痕妊娠持续至中晚孕的不良结局系统综述与荟萃分析
本系统综述与荟萃分析纳入20项研究432例持续至≥14周的剖宫产瘢痕妊娠(CSP),评估胎盘植入谱系疾病(PAS)与子宫切除风险。结果显示PAS汇总发生率0.90(95%CI 0.81–0.96),子宫切除汇总发生率0.39(95%CI 0.22–0.57),仅有0.19(95%CI 0.10–0.30)可妊娠至足月。CSP分型与残余肌层厚度是风险分层的关键决定因素。
要点
- 持续至中晚孕的CSP发生PAS风险极高,PAS汇总发生率0.90
- 子宫切除汇总发生率0.39,需在产前影像评估与咨询中重点提示
- III型与外生型CSP不良结局风险显著高于I、II型及内生型
核心结论
- III型及外生型CSP进展至中晚孕时,PAS与子宫切除风险显著升高,足月分娩可能性低
- I型、II型及内生型CSP不良结局风险相对较低
- CSP分型与残余肌层厚度是风险分层及个体化咨询的关键决定因素
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、EMBASE、Cochrane Library、ClinicalTrials.gov、CNKI及Yiigle数据库,时间截至2025年2月12日
- 纳入61项研究进行系统综述,其中20项研究432例纳入荟萃分析
- 纳入标准为单胎CSP持续≥14周且报告PAS和/或子宫切除率的研究
- 采用随机效应模型合并发生率及比值比,并按CSP亚型及残余肌层厚度进行亚组分析
关键影像表现/征象
- 定性分析显示存在严重临床表现,包括自发性子宫破裂及剖宫产术中大出血
- 报告子宫破裂的研究中,子宫破裂汇总发生率为0.05(95%CI 0.02–0.10)
诊断标准与关键数值
- PAS汇总发生率0.90(95%CI 0.81–0.96)
- 子宫切除汇总发生率0.39(95%CI 0.22–0.57)
- 达到≥28周汇总发生率0.85(95%CI 0.73–0.94),达到足月(≥37周)汇总发生率0.19(95%CI 0.10–0.30)
- III型与外生型CSP较I、II型及内生型的侵入性PAS、子宫切除及早产比值比均显著升高
- 残余肌层厚度≤3mm与总体及侵入性PAS比值比增加显著相关,且ROC分析显示可预测子宫切除
临床应用与阅片要点
- CSP持续至中晚孕时,阅片中应重点关注III型和外生型,其侵入性PAS、子宫切除及早产风险显著升高
- 残余肌层厚度≤3mm增加总体及侵入性PAS风险,并可用于预测子宫切除风险
- 产前影像结合CSP分型和残余肌层厚度进行分层,有助于外科准备及个体化咨询
- IV型(原文I、II型)及内生型CSP相对风险较低,可联合肌层厚度评估提供更细致的分层
局限性
- 纳入研究间存在显著异质性,采用随机效应模型合并分析
- 纳入荟萃分析的研究数量为20项,总例数432例,样本量较有限
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To review systematically and assess quantitatively the incidence and risk of placenta accreta spectrum (PAS) disorders and hysterectomy in Cesarean scar pregnancy (CSP) continuing into mid-to-late gestation.
METHODS: A comprehensive literature search was performed in PubMed, EMBASE, Cochrane Library, ClinicalTrials.gov, China National Knowledge Infrastructure (CNKI) and Yiigle databases from inception to 12 February 2025. Studies reporting the rates of PAS and/or hysterectomy in women with a singleton CSP that continued ≥ 14 weeks' gestation were eligible for inclusion. Data extracted included information on medical history, CSP classification and clinical manifestation, gestational age at delivery and pregnancy outcome. Data were synthesized as pooled incidences and odds ratios with 95% CIs, and random-effects models were used owing to high heterogeneity. Subgroup analyses were performed according to CSP subtype (Type I vs Type II vs Type III; and endogenous vs exogenous) and residual myometrial thickness (RMT) (≤ 3 mm vs > 3 mm).
RESULTS: Among 61 studies included in the systematic review, 20 studies (432 cases) were eligible for inclusion in the meta-analysis. Qualitative synthesis captured severe clinical phenotypes, including spontaneous uterine rupture and massive hemorrhage during Cesarean section. The pooled incidences of PAS and hysterectomy were 0.90 (95% CI, 0.81-0.96) and 0.39 (95% CI, 0.22-0.57), respectively. Marked heterogeneity was observed across CSP subtypes: Type-III and exogenous CSPs were associated with significantly higher odds of invasive PAS, hysterectomy and preterm delivery compared with Types-I/II and endogenous subtypes, respectively. Reduced RMT was associated significantly with increased odds of overall PAS and invasive PAS, and was predictive of hysterectomy on receiver-operating-characteristics-curve analysis. The pooled incidence of reaching ≥ 28 weeks' gestation was 0.85 (95% CI, 0.73-0.94), whereas the pooled incidence of reaching term (≥ 37 weeks) was 0.19 (95% CI, 0.10-0.30). Among studies that reported uterine rupture, the pooled incidence of this outcome was 0.05 (95% CI, 0.02-0.10).
CONCLUSIONS: Type-III and exogenous CSPs that progress into mid-to-late gestation present substantial risks for PAS and hysterectomy, with a low likelihood of term delivery. Type-I, Type-II and endogenous CSPs are associated with a comparatively lower risk of adverse outcome. CSP subtype and RMT are key determinants for risk stratification and individualized counseling. © 2026 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Zeng, Tian, Qu, et al. Adverse outcome in Cesarean scar pregnancy continuing into mid-to-late gestation: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2026. PMID: 42487537. doi:10.1002/uog.70293
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。